KPIs & Operating Metrics(New)
Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPensionProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nova (NVMI) Cash & Equivalents: 2009-2024

Historic Cash & Equivalents for Nova (NVMI) over the last 16 years, with FY2024 value amounting to $157.8 million.

  • Nova's Cash & Equivalents rose 23880.41% to $521.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $521.6 million, marking a year-over-year increase of 23880.41%. This contributed to the annual value of $157.8 million for FY2024, which is 4667.02% up from last year.
  • Per Nova's latest filing, its Cash & Equivalents stood at $157.8 million for FY2024, which was up 4667.02% from $107.6 million recorded in FY2023.
  • Nova's Cash & Equivalents' 5-year high stood at $232.3 million during FY2020, with a 5-year trough of $107.6 million in FY2023.
  • Over the past 5 years, Nova's median Cash & Equivalents value was $126.7 million (recorded in 2021), while the average stood at $147.1 million.
  • Per our database at Business Quant, Nova's Cash & Equivalents soared by 63171.22% in 2020 and then plummeted by 4546.03% in 2021.
  • Annual analysis of 5 years shows Nova's Cash & Equivalents stood at $232.3 million in 2020, then crashed by 45.46% to $126.7 million in 2021, then fell by 12.29% to $111.1 million in 2022, then dropped by 3.19% to $107.6 million in 2023, then soared by 46.67% to $157.8 million in 2024.
  • Its Cash & Equivalents was $157.8 million in FY2024, compared to $107.6 million in FY2023 and $111.1 million in FY2022.